- Bellerophon Therapeutics, Inc. stock price today and history
Bellerophon Therapeutics, Inc. (BLPH) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Bellerophon Therapeutics, Inc. stock price
Bellerophon Therapeutics, Inc. latest news:
Bellerophon shares surge 20% premarket on positive results in trial of COPD treatment
Bellerophon Therapeutics Inc. shares surged 20% in premarket trade, after the company reported positive results in a mid-stage trial of a treatment for pulmonary hypertension associated with chronic obstructive pulmonary disease. The company said the phase 2 trial of its INOpulse inhaled nitric oxide met its primary and secondary goals, showing statistically significant improvement in six-minute walking distance, hemodynamics and blood vessel volume. "COPD patients with associated pulmonary hypertension have a poor prognosis with an approximately 4-year life expectancy and high hospitalization rates, which represents a significant unmet medical need for a safe and effective long-term treatment," said Dr. Raymond L. Benza of the Cardiovascular Institute at Allegheny General Hospital, Pittsburgh, PA and Chairman of Bellerophon's PH-COPD steering committee. The company is planning to conduct a larger phase 2b study of the treatment. Shares have gained 117% in 2017, while the S&P 500 has gained 10.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Bellicum Pharmaceuticals, Inc.BLCM
Beneficial Bancorp, Inc.BNCL
Benitec Biopharma LimitedBNTC
Benitec Biopharma LimitedBNTCW
BG Medicine, Inc.BGMD
BGC Partners, Inc.BGCP
Big 5 Sporting Goods CorporationBGFV
BIND Therapeutics, Inc.BIND
Bio Blast Pharma Ltd.ORPN